Oxybutynin
- TRADE NAMES: Cystrin (Sanofi-Aventis); Ditropan (Ortho-McNeil); Dridase; Gelnique; Lyrinel (Janssen-Cilag); Novitropan; Oxyban; Oxybutyn; Oxytrol; Tropax; Uromax
- INDICATIONS: Neurogenic bladder, urinary incontinence, palmar and axillary hyperhidrosis
- CLASS: Anticholinergic, Muscarinic antagonist
- HALF-LIFE: 2–3 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Alcohol, Anticholinergics, Antihistamines, Arbutamine, Cannabinoids, Clozapine, Conivaptan, Diphenoxylate, Disopyramide, Domperidone, Haloperidol, Ketoconazole, Levodopa, MAO inhibitors, Memantine, Metoclopramide, Nefopam, Nitrates, Parasympathomimetics, Pramlintide, Secretin, Tricyclic antidepressants
PREGNANCY CATEGORY: B
Contra-indicated in patients with urinary retention, gastric retention and other severe decreased gastrointestinal motility conditions, uncontrolled narrow-angle glaucoma and in patients who are at risk for these conditions.
Please login to see the rest of this drug profile
SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OCULAR.
RESPIRATORY.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric